The role of Ga68 PSMA PET/CT imaging in Lu177 PSMA treatment planning in metastatic castration-resistant prostate cancer

被引：0
|
作者：
Mehmet Erdogan
Sevim S. Sengul
Bulent Cetin
Mustafa Avcı
Samet Yagci
Ismail Ozkoç
Damla Ezgi Barikan
Mustafa Yildiz
机构：
[1] Suleyman Demirel University Faculty of Medicine,Department of Nuclear Medicine
[2] Suleyman Demirel University Faculty of Medicine,Division of Medical Oncology, Department of Internal Medicine
来源：
Annals of Nuclear Medicine | 2022年 / 36卷
关键词：
Lutetium-177 PSMA; Gallium-68 PSMA; Metastatic castration resistant prostate cancer; TL PSMA; PSMA TV;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：562 / 569
页数：7
相关论文
共 50 条
  • [1] The role of Ga68 PSMA PET/CT imaging in Lu177 PSMA treatment planning in metastatic castration-resistant prostate cancer
    Erdogan, Mehmet
    Sengul, Sevim S.
    Cetin, Bulent
    Avci, Mustafa
    Yagci, Samet
    Ozkoc, Ismail
    Barikan, Damla Ezgi
    Yildiz, Mustafa
    ANNALS OF NUCLEAR MEDICINE, 2022, 36 (06) : 562 - 569
  • [2] PET/CT with 68Ga-PSMA for monitoring the treatment of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer
    Heinzel, A.
    Boghos, D.
    Mottaghy, F. M.
    Gaertner, F.
    Essler, M.
    von Mallek, D.
    Ahmadzadehfar, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S23 - S23
  • [3] 68Ga-PSMA PET/CT for monitoring response to 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer
    Heinzel, Alexander
    Boghos, Dima
    Mottaghy, Felix M.
    Gaertner, Florian
    Essler, Markus
    von Mallek, Dirk
    Ahmadzadehfar, Hojjat
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (05) : 1054 - 1062
  • [4] 68Ga-PSMA PET/CT for monitoring response to 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer
    Alexander Heinzel
    Dima Boghos
    Felix M. Mottaghy
    Florian Gaertner
    Markus Essler
    Dirk von Mallek
    Hojjat Ahmadzadehfar
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 1054 - 1062
  • [5] Treatment of castration-resistant metastatic prostate cancer with [177Lu]PSMA radioligand
    Sundset, Rune
    Haugnes, Hege Sagstuen
    Perez, Alexander
    Engelsen, Ola
    Fosseide, Ida H. H.
    Castillejo, Miguel J.
    Bogsrud, Trond Velde
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2024, 144 (09)
  • [6] 177Lu-PSMA for Extended Treatment of Metastatic Castration-Resistant Prostate Cancer
    Derlin, Thorsten
    Widjaja, Liam
    Werner, Rudolf A.
    Bengel, Frank M.
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (01) : 54 - 58
  • [7] 177Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer
    Sanli, Yasemin
    Simsek, Duygu Has
    Sanli, Oner
    Subramaniam, Rathan M.
    Kendi, Ayse Tuba
    BIOMEDICINES, 2021, 9 (04)
  • [8] Imaging of Metastatic Castration-Resistant Prostate Cancer - Comparison of 68Ga-RM2 and 68Ga-PSMA PET/CT
    Heuschkel, M.
    Kurth, J.
    Hakenberg, O. W.
    Schwarzenboeck, S. M.
    Krause, B. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S151 - S151
  • [9] Predictive Power of Radiomics Analysis of Pretreatment Ga-68 PSMA PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer Treated With Lu-177 PSMA for Treatment Response and Prognosis
    Temizer, E.
    Abdulrezzak, U.
    Goksuluk, D.
    Algur, D.
    Tutus, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S777 - S777
  • [10] Multicentric 68Ga-PSMA PET radiomics for treatment response assessment of 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer
    Gutsche, Robin
    Guelmues, Gizem
    Mottaghy, Felix M.
    Gaertner, Florian
    Essler, Markus
    von Mallek, Dirk
    Ahmadzadehfar, Hojjat
    Lohmann, Philipp
    Heinzel, Alexander
    FRONTIERS IN NUCLEAR MEDICINE, 2023, 3
12345